If the FDA meeting goes well, they could have the green light for the adult trial SR- aGVHD trial… on top of that the CLBP pivotal trial is recruiting. Both could finish recruiting by end of this year. Results early to mid next year. CLBP has a strong chance of an early stop and SR aGVHD has a short end point.
along side that, again if FDA meetings go to plan… two AA BLA’s could be submitted end of this year or early next.
Even before read outs, or outcomes from BLA’s are known… that is a lot of fuel to drive the share price higher, especially with all the recent funding behind us… it’s looking like a good run to mid 2025
goodluck all
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-480
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.020(1.50%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.562M | 2.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 17969 | 2 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |